NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.
Registering provides access to this and other free content.
Already have an account?Login Now.
Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.
About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.
Researchers examine plant and human DNA found on the Shroud of Turin.
In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.